This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Amyris
AMRS
0,04520 €
Share price
0.00%
Change (1 day)
-97.27%
Change (1 year)
Revenue for Amyris (AMRS)
Revenue in 2023 (TTM): €0.25 Billion
According to Amyris's latest financial reports the company's current revenue (TTM 
) is €0.24 Billion. In 2022 the company made a revenue of €0.25 Billion a decrease over the revenue in the year 2021 that were of €0.30 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Amyris from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | €0.25 B | 2.11% |
| 2022 | €0.25 B | -16.65% |
| 2021 | €0.30 B | 114.42% |
| 2020 | €0.14 B | 3.36% |
| 2019 | €0.13 B | 89.91% |
| 2018 | €71.71 M | -40.02% |
| 2017 | €0.11 B | 62.9% |
| 2016 | €73.38 M | 134.95% |
| 2015 | €31.23 M | -12.21% |
| 2014 | €35.58 M | 19.5% |
| 2013 | €29.77 M | -46.56% |
| 2012 | €55.71 M | -50.78% |
| 2011 | €0.11 B | 87.46% |
| 2010 | €60.37 M | 33.89% |
| 2009 | €45.09 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | €10.38 B | 4,181.54% | 🇺🇸 USA |
 | €4.86 B | 1,904.89% | 🇺🇸 USA |
 | €0.21 B | -9.28% | 🇺🇸 USA |
 | €2.22 B | 816.71% | 🇺🇸 USA |
 | €15.29 M | -93.69% | 🇺🇸 USA |
 | €11.19 B | 4,517.83% | 🇺🇸 USA |